NIH-funded research R21 grant

Keeping heart muscle cells connected as the heart ages

Official title: Regulation of Mechanical Coupling in Aging Myocardium

Funded at Lankenau Institute for Medical Research · NIH-11520493 · Data updated 2026-11-12

This project looks at whether strengthening the physical links between heart muscle cells can help aging hearts keep working better.

More Aging research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionLankenau Institute for Medical Research
NIH-funded
Lab location1 site (Wynnewood, United States)
Project startJune 15, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$73,588
NIH project number7R21AG077036-03
Project IDNIH-11520493 on NIH RePORTER

Who could benefit from this research

Could help

People most relevant to this work would be older adults with age-related heart stiffness or early-stage heart failure with preserved ejection fraction who might be candidates for future clinical therapies based on these mechanisms.

Less likely to help

Patients with acute heart attacks, congenital heart defects, or heart problems unrelated to aging may not directly benefit from these specific findings.

What this research studies

From a patient's perspective, researchers are using mouse models to understand how the connections between heart cells change with age. They will focus on proteins that physically link cells—especially vinculin, N-cadherin, and the Abl kinase pathway—and see how modifying those proteins affects heart stiffness and function. The team will test whether blocking certain modifications of vinculin or altering Abl kinase activity speeds up or slows age-related decline in heart performance. Findings aim to reveal basic mechanisms that might point to future treatments to preserve heart function in older adults.

Why it matters

Potential benefit: If successful, this work could identify new molecular targets to prevent or reduce age-related stiffening of the heart and lead to therapies that help older people maintain heart function.

How similar studies have gone: Previous research has suggested that changes in cytoskeletal proteins can protect the aging heart, but directly targeting vinculin phosphorylation and Abl kinase in this context is a novel, exploratory approach.

Where this research is happening

  • Lankenau Institute for Medical Research
    Wynnewood, United States
    Active

Researchers

  • Principal investigator: Radice, Glenn Lawrence — Lankenau Institute for Medical Research
  • Study coordinator: Radice, Glenn Lawrence

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.